Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoMero2 meropenem pharmacokinetics and safety study in infants with bacterial meningitis
NL-OMON39472Phase 2Active, not recruiting
- Sponsor
- Penta Foundation
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of meropenem in bacterial meningitis, sponsored by Penta Foundation. Primary endpoints: Plasma and cerebrospinal fluid pharmacokinetics of meropenem and Safety of meropenem. Started Feb 2013; status: active, not recruiting.
02
Drugs
meropenem
03
Conditions
bacterial meningitis
Beyond the preview
Go deeper on NL-OMON39472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39472.